Enhanced nicotinic receptor function and drug abuse vulnerability
- PMID: 17699659
- PMCID: PMC6672186
- DOI: 10.1523/JNEUROSCI.2017-06.2007
Enhanced nicotinic receptor function and drug abuse vulnerability
Abstract
In animals and humans, vulnerability to drug abuse varies among individuals. Animals that display high activity levels in a novel environment are more likely to self-administer psychostimulant drugs, including nicotine, cocaine, amphetamine, and morphine. Recent reports from behavioral studies indicate that nicotinic acetylcholine receptor (nAChR) activity contributes to the rewarding effects of several different addictive drugs. Thus, we hypothesized that differences in nAChR activity may contribute to the predisposition to drug self-administration. After screening of adult rats (>60 d postnatal) for the behavioral response to a novel environment, electrophysiological measures of nAChR function were conducted in brain slices that included the mesoaccumbens dopamine neurons of the ventral tegmental area (VTA). We found a positive correlation between the response to novelty and nAChR function in each assay conducted, including nAChR modulation of glutamatergic and GABAergic synaptic inputs to VTA dopamine neurons, as well as somatic nAChR responses of VTA neurons. The response to novelty and sensitivity to addictive drugs are positively correlated with the hormonal response to stress. Consistent with this observation, we found enhanced nAChR responses in vitro after a 48 h corticosterone treatment and in vivo after 48 h of repeated stress. Each of these effects was inhibited by RU486 (11beta-[p-(dimethylamino)phenyl]-17beta-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one) pretreatment, suggesting a steroid hormone receptor-dependent process. These findings suggest that differences in nAChR function within the mesoaccumbens dopamine system may contribute to individual differences in drug abuse vulnerability and that these are likely attributable to differences in stress hormone levels.
Figures






Similar articles
-
Nicotine-mediated activation of dopaminergic neurons in distinct regions of the ventral tegmental area.Neuropsychopharmacology. 2011 Apr;36(5):1021-32. doi: 10.1038/npp.2010.240. Epub 2011 Feb 2. Neuropsychopharmacology. 2011. PMID: 21289604 Free PMC article.
-
Distinctive nicotinic acetylcholine receptor functional phenotypes of rat ventral tegmental area dopaminergic neurons.J Physiol. 2009 Jan 15;587(2):345-61. doi: 10.1113/jphysiol.2008.162743. Epub 2008 Dec 1. J Physiol. 2009. PMID: 19047205 Free PMC article.
-
Differential modulation by nicotine of substantia nigra versus ventral tegmental area dopamine neurons.J Neurophysiol. 2007 Dec;98(6):3388-96. doi: 10.1152/jn.00760.2007. Epub 2007 Oct 17. J Neurophysiol. 2007. PMID: 17942622
-
Properties of distinct ventral tegmental area synapses activated via pedunculopontine or ventral tegmental area stimulation in vitro.J Physiol. 2009 Mar 15;587(Pt 6):1233-47. doi: 10.1113/jphysiol.2008.164194. Epub 2009 Feb 2. J Physiol. 2009. PMID: 19188251 Free PMC article.
-
Neurochemical and behavioral studies on ethanol and nicotine interactions.Neurosci Biobehav Rev. 2004 Jan;27(8):713-20. doi: 10.1016/j.neubiorev.2003.11.010. Neurosci Biobehav Rev. 2004. PMID: 15019421 Review.
Cited by
-
Presynaptic opioid and nicotinic receptor modulation of dopamine overflow in the nucleus accumbens.J Neurosci. 2008 Feb 13;28(7):1672-81. doi: 10.1523/JNEUROSCI.4275-07.2008. J Neurosci. 2008. PMID: 18272687 Free PMC article.
-
Exposure to nicotine and sensitization of nicotine-induced behaviors.Prog Neuropsychopharmacol Biol Psychiatry. 2007 Nov 15;31(8):1625-38. doi: 10.1016/j.pnpbp.2007.08.038. Epub 2007 Sep 1. Prog Neuropsychopharmacol Biol Psychiatry. 2007. PMID: 17936462 Free PMC article. Review.
-
α7 nicotinic acetylcholine receptor modulation of accumbal dopamine release covaries with novelty seeking.Eur J Neurosci. 2022 Mar;55(5):1162-1173. doi: 10.1111/ejn.15620. Epub 2022 Feb 22. Eur J Neurosci. 2022. PMID: 35141983 Free PMC article.
-
Age matters.Eur J Neurosci. 2009 Mar;29(5):997-1014. doi: 10.1111/j.1460-9568.2009.06648.x. Eur J Neurosci. 2009. PMID: 19291226 Free PMC article.
-
Allostatic load in opioid use disorder: a scoping review protocol.BMJ Open. 2023 Mar 17;13(3):e060522. doi: 10.1136/bmjopen-2021-060522. BMJ Open. 2023. PMID: 36931678 Free PMC article.
References
-
- Almeida LE, Pereira EF, Alkondon M, Fawcett WP, Randall WR, Albuquerque EX. The opioid antagonist naltrexone inhibits activity and alters expression of alpha7 and alpha4beta2 nicotinic receptors in hippocampal neurons: implications for smoking cessation programs. Neuropharmacology. 2000;39:2740–2755. - PubMed
-
- Blaha CD, Allen LF, Das S, Inglis WL, Latimer MP, Vincent SR, Winn P. Modulation of dopamine efflux in the nucleus accumbens after cholinergic stimulation of the ventral tegmental area in intact, pedunculopontine tegmental nucleus-lesioned, and laterodorsal tegmental nucleus-lesioned rats. J Neurosci. 1996;16:714–722. - PMC - PubMed
-
- Choi HK, Won LA, Kontur PJ, Hammond DN, Fox AP, Wainer BH, Hoffmann PC, Heller A. Immortalization of embryonic mesencephalic dopaminergic neurons by somatic cell fusion. Brain Res. 1991;552:67–76. - PubMed
-
- Dani JA. Roles of dopamine signaling in nicotine addiction. Mol Psychiatry. 2003;8:255–256. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources